Abstract
Background Artificial intelligence (AI) is expected to become an integral part of healthcare services, and the widespread adoption of AI tools in all areas of life is making AI accessible to the general public. Public perception of the benefits and risks of AI in healthcare is key to large-scale acceptance and implementation, and is increasingly influenced by first-hand experiences of AI. The aim of this study was to assess how exposure to ChatGPT changed public perception of AI in healthcare.
Methods We used baseline and follow-up data from 5,899 survey participants, who reported their perception of AI in 2022 and 2024, and ChatGPT use in 2024. Administrative and healthcare data from nationwide Danish registers was used for weighting and adjustment. Multinomial multivariate logistic regression was used to model how exposure to ChatGPT use affected changes in perception of AI.
Results At baseline (before ChatGPT’s launch) 2,236 individuals (37%) were unsure of the benefits and risks of AI in healthcare, 2,384 (40%) perceived net benefits, 1,083 (18%) perceived benefits and risks as equal, and 196 (3.3%) perceived net risks. At follow-up, 1,195 individuals (20%) had been exposed to ChatGPT use, which was associated with higher odds of changing perception of AI to benefits (OR 3.21 [95% CI: 2.34-4.40]) among individuals who were unsure at baseline, and lower odds of changing to uncertainty from more defined baseline perceptions (from benefits (OR 0.32 [0.24-0.42]), equal (OR 0.47 [0.32-0.69]) and risks (OR 0.27 [0.08-0.98])).
Conclusion Exposure to ChatGPT was associated with a change towards positive perception of benefits and risks of AI in healthcare among individuals who were uncertain prior to exposure, and individuals with more defined perceptions of AI were less likely to become uncertain after exposure to ChatGPT.
Competing Interest Statement
AAI, JRS, LB, and AH are employed at Steno Diabetes Center Aarhus which is partly funded by an unrestricted grant from the Novo Nordisk Foundation (NNF17SA0031230). AAI and AH are supported by a Data Science Emerging Investigator grant (NNF22OC0076725) by the Novo Nordisk Foundation. The funders had no role in the design of the study.
Clinical Protocols
https://figshare.com/articles/online_resource/_/26048662?file=47115853
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the Health In Central Denmark Study at Steno Diabetes Center Aarhus gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.